Quest Diagnostics (DGX) Other financing activities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Other financing activities data on file, last reported at -$84.0 million in Q1 2026.

• Quarterly Other financing activities fell 37.7% year-over-year to -$84.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (up 33.33% YoY) and the FY2025 annual result came in at $39.0 million, up 85.71% from the prior year.
• Other financing activities fell to -$84.0 million in Q1 2026 per DGX's latest filing, from $100.0 million in the prior quarter.
• The five-year high for Other financing activities was $100.0 million in Q4 2025, with the low at -$84.0 million in Q1 2026.
• Average Other financing activities over 5 years is -$2.9 million, with a median of $3.0 million recorded in 2024.
• The widest YoY moves for Other financing activities: up 244.44% in 2023, down 866.67% in 2023.
• Quest Diagnostics' Other financing activities stood at -$20.0 million in 2022, then soared by 190.0% to $18.0 million in 2023, then jumped by 216.67% to $57.0 million in 2024, then jumped by 75.44% to $100.0 million in 2025, then slumped by 184.0% to -$84.0 million in 2026.
• Business Quant data shows DGX's Other financing activities at -$84.0 million in Q1 2026, $100.0 million in Q4 2025, and -$11.0 million in Q3 2025.